Envista’s Re-branding of KaVo Imaging Business Makes Waves in Dental Imaging Market

Dental imaging devices

Envista recently announced that they will be re-branding their KaVo imaging business as “DEXIS”. According to Envista, this re-branding will allow the DEXIS brand to encompass a complete portfolio of outstanding imaging devices and digital solutions including cone-beam computed tomography (CBCT), handheld x-rays, intraoral scanners, sensors, and navigated surgical solutions.


For those who are unaware, Envista Holdings Corporation Inc. is a family of over 30 trusted dental brands and operates largely through three main companies: Ormco, Nobel Biocare Systems, and of course KaVo Kerr. The company predicts that over the remainder of 2022, the re-branding of KaVo to DEXIS will take place with varying schedules dependent on product and region.

From Seeking Alpha, Envista (NVST) expects the newly branded DEXIS IOS business to deliver between $35M-$45M in sales over 2022. According to the CEO of Envista Holdings Corporation Inc., he states that “we are excited to unite our imaging portfolio under the DEXIS brand and unveil our new DEXIS logo that will be featured on our entire imaging portfolio. This is one step in our continued efforts to create integrated, digital workflows that connect all our products and enable dental professionals to treat and improve more patient lives. We are living out our strategy to digitize, personalize, and democratize dentistry and look forward to the future.”


In the past, KaVo Kerr was a dominant player in the dental imaging market and held a significant share over other competitors. Heavy product consolidation occurred after the company purchased other companies like Aribex, i-CAT™, Instrumentarium, Soredex, Gendex, and Dexis. 

In terms of specific segments, KaVo Kerr had a dominant stance in the digital sensor segment of the intraoral imaging market. Two companies purchased by KaVo Kerr, Dexis and Gendex, have historically had great success in the intraoral imaging market. Subsequently, the release of the FS Ergo™, a sensor with a flexible casing, allowed the company to increase its share of the premium market. 


Previously, U.S. and European dental imaging device market reports were combined to create a global series. However, iData has decided to expand their research scope for the upcoming 2022 dental imaging series to include a complete global report. The brand-new global dental imaging devices market report will include coverage from several additional regions including: 

  • North America (Canada and the U.S.)
  • Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela)
  • Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.)
  • Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic,Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine)
  • Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates)
  • Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan,Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea,Taiwan, Thailand, Vietnam)
  • Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa,Sudan, Uganda).

iData’s analysis will also include detailed segmentation on the following markets including extraoral x-ray imaging devices, intraoral x-ray imaging devices, and cone beam computed tomography scanners. Furthermore, detailed segmentation of each market will include intraoral x-ray devices, PSP systems, digital sensors, intraoral analog x-ray films, PSP plates, and more.

Contact us to receive a pre-publication synopsis for the Global Dental Imaging Devices Market Report

Via: Envista Holdings Corporation (“Envista”)

Leave a Reply